Literature DB >> 30293618

Frailty and clinical benefits with lung transplantation.

Dmitry Rozenberg1, Sunita Mathur2, Lisa Wickerson3, Noori A Chowdhury4, Lianne G Singer5.   

Abstract

BACKGROUND: The Fried frailty phenotype is associated with morbidity and mortality in lung transplant (LTx) candidates, but its clinical application and association with post-transplant outcomes are not well defined. We assessed 2 alternate frailty indices in LTx candidates and evaluated associations of frailty with early post-transplant outcomes and 1-year mortality.
METHODS: Frailty was prospectively evaluated in 50 LTx candidates using the Fried and 2 alternate phenotypic indices, one using variables readily available to clinicians and one using variables from an existing data set. Agreement between indices and associations with related measures were assessed to establish validity. The data set index was then applied retrospectively to 221 LTx patients. Post-transplant outcomes were compared between frail and non-frail patients using t-tests and multivariable regression analysis.
RESULTS: Frailty prevalence among the 3 indices was 26% to 30%, and the κ agreement was 0.38 to 0.41. All indices had moderate correlations with London Chest Activity of Daily Living (r = 0.48-0.62) and Short-Physical Performance Battery (r = -0.43 to -0.52). In the retrospective cohort, frail LTx candidates had a worse St. George's Respiratory Questionnaire total score (73 ± 12vs 62 ± 12, p < 0.001). Frail candidates had a larger improvement with transplant in the St. George's Respiratory Questionnaire (-52 ± 19vs -43 ± 18, p = 0.002) and 6-minute walk distance (191 ± 119vs 129 ± 94m, p = 0.001). Frailty was not associated with hospital length of stay or 1-year mortality.
CONCLUSIONS: There was good construct validity and acceptable agreement among the frailty indices. Despite significant disability pre-transplant, frail LTx candidates derived significant benefit with transplantation.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  exercise capacity; frailty; lung transplantation; post-transplant outcome; quality of life

Mesh:

Year:  2018        PMID: 30293618     DOI: 10.1016/j.healun.2018.06.005

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  13 in total

1.  Discussion: An Analysis of the Modified Five-Item Frailty Index for Predicting Complications following Free Flap Breast Reconstruction.

Authors:  Robyn N Rubenstein; Robert J Allen; Jonas A Nelson
Journal:  Plast Reconstr Surg       Date:  2022-01-01       Impact factor: 4.730

2.  Frailty and the Potential Kidney Transplant Recipient: Time for a More Holistic Assessment?

Authors:  Henry H L Wu; Alexander Woywodt; Andrew C Nixon
Journal:  Kidney360       Date:  2020-05-22

3.  Predictive value of chart-based frailty evaluation for lung transplant candidates.

Authors:  Serina Gee; Yoon Lee; Aloukika Shah; Ehsan Izadmehr; John Belperio; Yusaku Shino; Sam Weigt; Deena Goldwater; Joanna Schaenman
Journal:  Clin Transplant       Date:  2021-09-23       Impact factor: 3.456

4.  Frailty after lung transplantation is associated with impaired health-related quality of life and mortality.

Authors:  Aida Venado; Nicholas A Kolaitis; Chiung-Yu Huang; Ying Gao; David V Glidden; Allison Soong; Nicole Sutter; Patricia P Katz; John R Greenland; Daniel R Calabrese; Steven R Hays; Jeffrey A Golden; Rupal J Shah; Lorriana E Leard; Jasleen Kukreja; Tobias Deuse; Paul J Wolters; Kenneth Covinsky; Paul D Blanc; Jonathan P Singer
Journal:  Thorax       Date:  2020-05-06       Impact factor: 9.139

5.  Improvements in frailty contribute to substantial improvements in quality of life after lung transplantation in patients with cystic fibrosis.

Authors:  Alyssa A Perez; Steven R Hays; Allison Soong; Ying Gao; John R Greenland; Lorriana E Leard; Rupal J Shah; Jeffrey Golden; Jasleen Kukreja; Aida Venado; Mary Ellen Kleinhenz; Jonathan P Singer
Journal:  Pediatr Pulmonol       Date:  2020-04-01

Review 6.  Frailty and aging-associated syndromes in lung transplant candidates and recipients.

Authors:  Joanna M Schaenman; Joshua M Diamond; John R Greenland; Cynthia Gries; Cassie C Kennedy; Amit D Parulekar; Dmitry Rozenberg; Jonathan P Singer; Lianne G Singer; Laurie D Snyder; Sangeeta Bhorade
Journal:  Am J Transplant       Date:  2020-12-24       Impact factor: 9.369

Review 7.  Measuring frailty in younger populations: a rapid review of evidence.

Authors:  Gemma F Spiers; Tafadzwa Patience Kunonga; Alex Hall; Fiona Beyer; Elisabeth Boulton; Stuart Parker; Peter Bower; Dawn Craig; Chris Todd; Barbara Hanratty
Journal:  BMJ Open       Date:  2021-03-22       Impact factor: 2.692

8.  Recovery of physical function in lung transplant recipients with sarcopenia.

Authors:  Etsuhiro Nikkuni; Takashi Hirama; Kazuki Hayasaka; Sakiko Kumata; Shinichi Kotan; Yui Watanabe; Hisashi Oishi; Hiromichi Niikawa; Masahiro Kohzuki; Yoshinori Okada
Journal:  BMC Pulm Med       Date:  2021-04-16       Impact factor: 3.317

Review 9.  Lung transplantation: a review of the optimal strategies for referral and patient selection.

Authors:  Alicia B Mitchell; Allan R Glanville
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

Review 10.  Timing it right: the challenge of recipient selection for lung transplantation.

Authors:  Henry W Ainge-Allen; Allan R Glanville
Journal:  Ann Transl Med       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.